Literature DB >> 12411807

Biphasic effects of isoflurane on the cardiac action potential: an ionic basis for anesthetic-induced changes in cardiac electrophysiology.

Akihiro Suzuki1, Kei Aizawa, Susanne Gassmayr, Zeljko J Bosnjak, Wai-Meng Kwok.   

Abstract

BACKGROUND: The mechanism underlying isoflurane modulation of cardiac electrophysiology is not well understood. In the present study, the authors investigated the effects of isoflurane on the cardiac action potential (AP) characteristics. The results were correlated to modulation of the L-type calcium (I(Ca,L)), the delayed-rectifier potassium (I(Kdr)), and the inward-rectifier potassium (I(Kir)) currents.
METHODS: Single ventricular myocytes were enzymatically isolated from guinea pig hearts. The current clamp and whole cell voltage clamp configurations of the patch clamp technique were used to monitor the cardiac AP and ionic currents, respectively. A dynamic AP voltage protocol that mimicked changes in membrane potential during an AP was used to monitor the I(Ca,L), I(Kdr) and I(Kir).
RESULTS: Isoflurane produced a concentration-dependent, biphasic effect on the AP duration (APD). At 0.6 mm (1.26 vol%), isoflurane significantly increased APD50 and APD90 by 50.0 +/- 7.6% and 48.9 +/- 7.2%, respectively (P < 0.05; n = 6). At 1.0 mm (2.09 vol%), isoflurane had no significant effect on APD (n = 6). In contrast, at 1.8 mm (3.77 vol%), isoflurane decreased APD50 and APD90 by 38.3 +/- 5.4% and 32.2 +/- 5.5%, respectively (P < 0.05; n = 7). The inhibitory effects of isoflurane on I(Kdr) chord conductance were greater than those on I(Ca,L) (P < 0.05; n = 6/group). Both I(Ca,L) inactivation and I(Kdr) activation kinetics were accelerated by isoflurane. Isoflurane had no significant effects on I(Kir) chord conductance (n = 6).
CONCLUSION: At the lower anesthetic concentration, the prolongation of the APD may be the result of the dominant inhibitory effects of isoflurane on I(Kdr). At the higher concentration, the shortening of the APD may be caused by the inhibitory effects on I (Ca,L) combined with the isoflurane-induced acceleration of I(Ca,L) inactivation kinetics. Because I(Kdr) is significantly inhibited by isoflurane, I(Kir) appears to be the major repolarizing current, which is minimally affected by isoflurane.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12411807     DOI: 10.1097/00000542-200211000-00026

Source DB:  PubMed          Journal:  Anesthesiology        ISSN: 0003-3022            Impact factor:   7.892


  6 in total

1.  Enhanced effects of isoflurane on the long QT syndrome 1-associated A341V mutant.

Authors:  Ikuomi Mikuni; Carlos G Torres; Tania Bakshi; Akihito Tampo; Brian E Carlson; Martin W Bienengraeber; Wai-Meng Kwok
Journal:  Anesthesiology       Date:  2015-04       Impact factor: 7.892

2.  Isoflurane Modulates Hippocampal Cornu Ammonis Pyramidal Neuron Excitability by Inhibition of Both Transient and Persistent Sodium Currents in Mice.

Authors:  Wenling Zhao; Mingyue Zhang; Jin Liu; Peng Liang; Rurong Wang; Hugh C Hemmings; Cheng Zhou
Journal:  Anesthesiology       Date:  2019-07       Impact factor: 7.892

3.  Accelerated inactivation of cardiac L-type calcium channels triggered by anaesthetic-induced preconditioning.

Authors:  A Tampo; C S Hogan; F Sedlic; Z J Bosnjak; W M Kwok
Journal:  Br J Pharmacol       Date:  2009-02-16       Impact factor: 8.739

4.  Different sensitivity to the suppressive effects of isoflurane anesthesia on cardiorespiratory function in SHR/Izm, WKY/Izm, and Crl:CD (SD) rats.

Authors:  Kouki Kato; Jun Wakai; Kazunori Ozawa; Miho Sekiguchi; Kiyoaki Katahira
Journal:  Exp Anim       Date:  2016-06-10

5.  The General Anesthetic Isoflurane Bilaterally Modulates Neuronal Excitability.

Authors:  Mengchan Ou; Wenling Zhao; Jin Liu; Peng Liang; Han Huang; Hai Yu; Tao Zhu; Cheng Zhou
Journal:  iScience       Date:  2019-12-10

6.  Combining patient proteomics and in vitro cardiomyocyte phenotype testing to identify potential mediators of heart failure with preserved ejection fraction.

Authors:  Roseanne Raphael; Diana Purushotham; Courtney Gastonguay; Marla A Chesnik; Wai-Meng Kwok; Hsiang-En Wu; Sanjiv J Shah; Shama P Mirza; Jennifer L Strande
Journal:  J Transl Med       Date:  2016-01-20       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.